According to CinCor Pharma's latest financial reports the company has a price-to-book ratio of 2.45.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 1.04 | -111.2% |
2021-12-31 | -9.25 | |
2020-12-31 | N/A |